Relay Therapeutics, Inc. (RLAY)
7.795
-0.20
(-2.44%)
USD |
NASDAQ |
Jan 12, 16:00
7.795
0.00 (0.00%)
After-Hours: 17:46
Relay Therapeutics Total Assets (Quarterly): 670.00M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 114.94B |
| Theravance Biopharma, Inc. | 415.46M |
| Prelude Therapeutics, Inc. | 94.76M |
| Immunome, Inc. | 299.38M |
| ImmunityBio, Inc. | 518.99M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 62.29M |
| Shareholders Equity (Quarterly) | 607.71M |
| Debt to Equity Ratio | 0.0548 |
| Current Ratio | 19.14 |
| Net Debt Paydown Yield | 0.39% |